Abstract
Interpreting the phenotypes of blaSHV alleles in Klebsiella pneumoniae genomes is complex. Whilst all strains are expected to carry a chromosomal copy conferring resistance to ampicillin, they may also carry mutations in chromosomal blaSHV alleles or additional plasmid-borne blaSHV alleles that have extended-spectrum β-lactamase (ESBL) activity and/or β-lactamase inhibitor (BLI) resistance activity. In addition, the role of individual mutations/a changes is not completely documented or understood. This has led to confusion in the literature and in antimicrobial resistance (AMR) gene databases [e.g. the National Center for Biotechnology Information (NCBI) Reference Gene Catalog and the β-lactamase database (BLDB)] over the specific functionality of individual sulfhydryl variable (SHV) protein variants. Therefore, the identification of ESBL-producing strains from K. pneumoniae genome data is complicated. Here, we reviewed the experimental evidence for the expansion of SHV enzyme function associated with specific aa substitutions. We then systematically assigned SHV alleles to functional classes (WT, ESBL and BLI resistant) based on the presence of these mutations. This resulted in the re-classification of 37 SHV alleles compared with the current assignments in the NCBI's Reference Gene Catalog and/or BLDB (21 to WT, 12 to ESBL and 4 to BLI resistant). Phylogenetic and comparative genomic analyses support that (i) SHV-1 (encoded by blaSHV-1) is the ancestral chromosomal variant, (ii) ESBL- and BLI-resistant variants have evolved multiple times through parallel substitution mutations, (iii) ESBL variants are mostly mobilized to plasmids and (iv) BLI-resistant variants mostly result from mutations in chromosomal blaSHV. We used matched genome-phenotype data from the KlebNET-GSP AMR Genotype-Phenotype Group to identify 3999 K. pneumoniae isolates carrying one or more blaSHV alleles but no other acquired β-lactamases to assess genotype-phenotype relationships for blaSHV. This collection includes human, animal and environmental isolates collected between 2001 and 2021 from 24 countries. Our analysis supports that mutations at Ambler sites 238 and 179 confer ESBL activity, whilst most omega-loop substitutions do not. Our data also provide support for the WT assignment of 67 protein variants, including 8 that were noted in public databases as ESBL. These eight variants were reclassified as WT because they lack ESBL-associated mutations, and our phenotype data support susceptibility to third-generation cephalosporins (SHV-27, SHV-38, SHV-40, SHV-41, SHV-42, SHV-65, SHV-164 and SHV-187). The approach and results outlined here have been implemented in Kleborate v2.4.1 (a software tool for genotyping K. pneumoniae), whereby known and novel blaSHV alleles are classified based on causative mutations. Kleborate v2.4.1 was updated to include ten novel protein variants from the KlebNET-GSP dataset and all alleles in public databases as of November 2023. This study demonstrates the power of sharing AMR phenotypes alongside genome data to improve the understanding of resistance mechanisms.
| Original language | English |
|---|---|
| Article number | 001294 |
| Number of pages | 18 |
| Journal | Microbial Genomics |
| Volume | 10 |
| Issue number | 10 |
| Early online date | 21 Oct 2024 |
| DOIs | |
| Publication status | Published - 21 Oct 2024 |
Bibliographical note
Publisher Copyright:© 2024 The Authors.
Data Availability Statement
All supporting data, code and protocols have been provided within the article or through supplementary data files. Two supplementary figures and five supplementary tables are available in the online version of this article.Funding
This work was supported, in whole or in part, by the Bill and Melinda Gates Foundation (OPP025280). Under the grant conditions of the foundation, a Creative Commons Attribution 4.0 Generic License has already been assigned to the author accepted manuscript version that might arise from this submission. This work was also supported financially by the MedVetKlebs project from the European Joint Programme One Health, which has received funding from the European Union\u2019s Horizon 2020 Research and Innovation Programme under Grant Agreement No. 773830.
| Funders | Funder number |
|---|---|
| Bill and Melinda Gates Foundation | OPP025280 |
| Horizon 2020 Framework Programme | 773830 |
Keywords
- AMR
- BLI resistance
- extended-spectrum β-lactamase (ESBL)
- genotype
- K. pneumoniae
- prediction
- SHV
- β-lactamase
ASJC Scopus subject areas
- Epidemiology
- Microbiology
- Molecular Biology
- Genetics
Fingerprint
Dive into the research topics of 'Diversity, functional classification and genotyping of SHV β-lactamases in Klebsiella pneumoniae'. Together they form a unique fingerprint.Projects
- 2 Finished
-
Tools for the Epidemiology of AMR Plasmids, One-Health Transmission and Surveillance
Feil, E. (PI)
13/02/23 → 12/08/24
Project: Research council
-
SpARK - The Rates and Routes of Transmission of Multidrug Resistant Klebsiella Clones into the Clinic from Environmental Sources
Feil, E. (PI)
1/04/17 → 31/12/20
Project: Research council
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS